BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29593009)

  • 1. Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence.
    Brantley KD; Kjærsgaard A; Cronin-Fenton D; Yacoub R; Nielsen AS; Lauridsen KL; Hamilton-Dutoit S; Lash TL
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):653-659. PubMed ID: 29593009
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study.
    Hjorth CF; Nielsen AS; Sørensen HT; Lash TL; Damkier P; Hamilton-Dutoit S; Cronin-Fenton D
    Acta Oncol; 2019 Feb; 58(2):168-174. PubMed ID: 30458661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin does not appear to influence breast cancer recurrence risk.
    Collin LJ; Cronin-Fenton DP; Ahern TP; Christensen KB; Damkier P; Hamilton-Dutoit S; Kjaersgaard A; Lauridsen KL; Yacoub R; Christiansen P; Sørensen HT; Lash TL
    Acta Oncol; 2019 Feb; 58(2):154-161. PubMed ID: 30351173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
    Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
    PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study.
    Thistle JE; Hellberg Y; Mortensen K; Hamilton-Dutoit S; Kjærsgaard A; Cronin-Fenton D; Sørensen HT; Lash TL
    Breast Cancer Res Treat; 2017 Oct; 165(3):633-643. PubMed ID: 28643021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospect of a stanniocalcin endocrine/paracrine system in mammals.
    Ishibashi K; Imai M
    Am J Physiol Renal Physiol; 2002 Mar; 282(3):F367-75. PubMed ID: 11832417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study.
    Collin LJ; Maliniak ML; Cronin-Fenton DP; Ahern TP; Christensen KB; Ulrichsen SP; Damkier P; Hamilton-Dutoit S; Yacoub R; Christiansen PM; Sørensen HT; Lash TL
    Breast Cancer Res; 2021 Nov; 23(1):103. PubMed ID: 34736510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.
    Raulic S; Ramos-Valdes Y; DiMattia GE
    J Endocrinol; 2008 Jun; 197(3):517-29. PubMed ID: 18492817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary.
    Luo CW; Pisarska MD; Hsueh AJ
    Endocrinology; 2005 Jan; 146(1):469-76. PubMed ID: 15486227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.
    Ahern TP; Cronin-Fenton DP; Lash TL; Sørensen HT; Ording AG; Hamilton-Dutoit SJ; Hellberg Y
    Acta Oncol; 2016 Jun; 55(6):734-41. PubMed ID: 27056567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration.
    Yamamoto K; Tajima Y; Hasegawa A; Takahashi Y; Kojima M; Watanabe R; Sato K; Shichiri M; Watanabe T
    Peptides; 2016 Aug; 82():120-127. PubMed ID: 27346255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells.
    Jellinek DA; Chang AC; Larsen MR; Wang X; Robinson PJ; Reddel RR
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):453-61. PubMed ID: 10947959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
    Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V
    J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.
    Bouras T; Southey MC; Chang AC; Reddel RR; Willhite D; Glynne R; Henderson MA; Armes JE; Venter DJ
    Cancer Res; 2002 Mar; 62(5):1289-95. PubMed ID: 11888893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
    Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
    Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
    Jansen MP; Sas L; Sieuwerts AM; Van Cauwenberghe C; Ramirez-Ardila D; Look M; Ruigrok-Ritstier K; Finetti P; Bertucci F; Timmermans MM; van Deurzen CH; Martens JW; Simon I; Roepman P; Linn SC; van Dam P; Kok M; Lardon F; Vermeulen PB; Foekens JA; Dirix L; Berns EM; Van Laere S
    Mol Oncol; 2015 Jun; 9(6):1218-33. PubMed ID: 25771305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study.
    Aydin HA; Toptas T; Bozkurt S; Aydin A; Erdogan G; Pestereli E; Simsek T
    Pathol Oncol Res; 2019 Apr; 25(2):751-757. PubMed ID: 30661222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian stanniocalcins and cancer.
    Chang AC; Jellinek DA; Reddel RR
    Endocr Relat Cancer; 2003 Sep; 10(3):359-73. PubMed ID: 14503913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
    Law AY; Wong CK
    Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four stanniocalcin genes in teleost fish: structure, phylogenetic analysis, tissue distribution and expression during hypercalcemic challenge.
    Schein V; Cardoso JC; Pinto PI; Anjos L; Silva N; Power DM; Canário AV
    Gen Comp Endocrinol; 2012 Jan; 175(2):344-56. PubMed ID: 22154646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.